Non-cirrhotic metabolic dysfunctionassociated steatohepatitis (MASH) with moderate to advanced liver fibrosis maintenance dose: 2.4 mg injected once weekly
Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine
Accurate and detailed discharge documentation is imperative to inform other healthcare professionals, especially GPs and community pharmacists, of the reaction, causative medicine, complications and follow-up plans, in line with the National Institute for Health and Care Excellence guidelines for drug allergy diagnosis and management in the UK, for example [12], [70]
Best for weight management programs, GLP-1 medication adjunct, and metabolic health goals
Suggested usage Consume 10 teaspoons (50 ml) of this product no more than once daily
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR